[HTML][HTML] Complications of HIV disease and antiretroviral therapy
AF Luetkemeyer, DV Havlir… - Topics in antiviral medicine, 2012 - ncbi.nlm.nih.gov
Studies on the efficacy of and drug interactions with the hepatitis C virus (HCV) direct-acting
antivirals (DAAs) in HCV/HIV coinfection were a highlight of the 2012 Conference on …
antivirals (DAAs) in HCV/HIV coinfection were a highlight of the 2012 Conference on …
Therapy insight: the changing spectrum of rheumatic disease in HIV infection
RM Maganti, JD Reveille, FM Williams - Nature Clinical Practice …, 2008 - nature.com
HIV infection and AIDS have protean and multisystem manifestations throughout the various
stages of infection. Progression from HIV infection to AIDS is associated with a gradual loss …
stages of infection. Progression from HIV infection to AIDS is associated with a gradual loss …
[引用][C] COVID-19 and psoriasis: is it time to limit treatment with immunosuppressants? A call for action.
MD Claudio Conforti, MD Roberta Giuffrida…
Endocrine considerations in ever-improving HIV-related mortality outcomes: a clinical perspective
S Mensforth, B Jose, G Varughese… - Endocrine …, 2014 - endocrine-abstracts.org
Since the advent of effective combined antiretroviral therapy (ART), mortality due to HIV
disease has significantly declined. Changing trends in HIV-associated morbidity is surfacing …
disease has significantly declined. Changing trends in HIV-associated morbidity is surfacing …
How to manage metabolic complications of HIV therapy: what to do while we wait for answers.
JS Currier - The AIDS reader, 2000 - europepmc.org
Although effective treatment of antiretroviral-associated metabolic abnormalities ultimately
depends on understanding the mechanisms involved, clinicians facing these problems are …
depends on understanding the mechanisms involved, clinicians facing these problems are …
Reducing medical comorbidities associated with long-term HIV infection: beyond optimizing antiretroviral therapy regimens
NJ Dharan, DA Cooper - AIDS, 2017 - journals.lww.com
Non-AIDS-related comorbidities, such as cardiovascular disease [1, 2], liver disease [3],
kidney disease [1, 4], and non-AIDS defining malignancies [2], occur in persons with HIV in …
kidney disease [1, 4], and non-AIDS defining malignancies [2], occur in persons with HIV in …
Immunomodulatory and anti-inflammatory strategies to reduce comorbidity risk in people with HIV
A Kettelhut, E Bowman, NT Funderburg - Current HIV/AIDS Reports, 2020 - Springer
Abstract Purpose of Review In this review, we will discuss treatment interventions targeting
drivers of immune activation and chronic inflammation in PWH. Recent Findings Potential …
drivers of immune activation and chronic inflammation in PWH. Recent Findings Potential …
HIV-related metabolic comorbidities in the current ART era
AH Warriner, GA Burkholder… - Infectious Disease Clinics, 2014 - id.theclinics.com
The widespread use of potent combination antiretroviral therapy (ART) has produced
significant gains in survival, 1–4 resulting in an aging HIV-infected population in developed …
significant gains in survival, 1–4 resulting in an aging HIV-infected population in developed …
[PDF][PDF] Metabolic Complications of HIV Infection
LM Chirch, P Luthra, F Mirza - Journal of Clinical Outcomes …, 2017 - cdn.mdedge.com
• Results: People with HIV infection are living longer thanks to the advent of potent
antiretroviral therapy. This has led to increased incidence of age-related metabolic …
antiretroviral therapy. This has led to increased incidence of age-related metabolic …
HIV-related skin disease in the era of antiretroviral therapy: recognition and management
K Chelidze, C Thomas, AY Chang… - American journal of …, 2019 - Springer
Antiretroviral therapy (ART) has revolutionized the treatment and prognosis of people living
with HIV (PLHIV). With increased survival and improved overall health, PLHIV are …
with HIV (PLHIV). With increased survival and improved overall health, PLHIV are …